Response to immune checkpoint inhibitors in acral melanoma: A nationwide cohort study

MLA

Pathologie Pathologen staf, et al. Response to Immune Checkpoint Inhibitors in Acral Melanoma: A Nationwide Cohort Study. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1432118742&authtype=sso&custid=ns315887.

APA

Pathologie Pathologen staf, Cancer, MS Medische Oncologie, Infection & Immunity, van Not, O. J., de Meza, M. M., van den Eertwegh, A. J. M., Haanen, J. B., Blank, C. U., Aarts, M. J. B., van den Berkmortel, F. W. P. J., van Breeschoten, J., de Groot, J.-W. B., Hospers, G. A. P., Ismail, R. K., Kapiteijn, E., Piersma, D., van Rijn, R. S., Stevense-den Boer, M. A. M., … Suijkerbuijk, K. P. M. (2022). Response to immune checkpoint inhibitors in acral melanoma: A nationwide cohort study.

Chicago

Pathologie Pathologen staf, Cancer, MS Medische Oncologie, Infection & Immunity, Olivier J van Not, Melissa M de Meza, Alfons J M van den Eertwegh, et al. 2022. “Response to Immune Checkpoint Inhibitors in Acral Melanoma: A Nationwide Cohort Study.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1432118742&authtype=sso&custid=ns315887.